NCT00318539View on ClinicalTrials.gov

Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

December 31, 2003

Study Completion Date

August 31, 2006

Conditions
Obsessive Compulsive Disorder
Interventions
DRUG

Quetiapine

Trial Locations (1)

Unknown

Research Site, Utrecht

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY